Nippon Paper Industries Co (3863) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
19 Aug, 2025Executive summary
Net sales for Q1–Q3 FY2025/3 rose 1.3% year-over-year to ¥886.3 billion, driven by growth in household paper, healthcare products, and chemicals, offsetting lower graphic paper demand.
Operating income increased 19.2% year-over-year to ¥11.1 billion, supported by strong domestic daily-life products and energy businesses.
Ordinary income surged 68.4% year-over-year to ¥12.8 billion.
Net income improved significantly, reaching ¥8.4 billion in Q3 after a loss in Q1, with cumulative net income of ¥0.1 billion for Q1–Q3 and profit attributable to owners of parent at ¥57 million.
Financial highlights
Gross profit improved to ¥139.7 billion from ¥131.3 billion year-over-year.
Operating income margin increased, with operating income at ¥11.1 billion versus ¥9.3 billion last year.
Net income per share was ¥0.50, compared to a loss of ¥71.89 per share in the previous year.
Comprehensive income was ¥3.0 billion, down from ¥24.6 billion year-over-year.
Capital expenditure for Q1–Q3 FY2025/3 was ¥58.1 billion; depreciation at ¥58.7 billion.
Outlook and guidance
FY2025/3 full-year net sales forecast is ¥1,200.0 billion, up 2.8% year-over-year.
Operating income is projected at ¥23.0 billion, a 33.2% increase year-over-year.
Ordinary income forecast is ¥19.0 billion, up 30.6% year-over-year.
Net income forecast is ¥3.0 billion, up 86.8% year-over-year due to prior year one-time gains.
Dividend forecast is ¥10 per share for year-end, unchanged from the previous year.
Latest events from Nippon Paper Industries Co
- Operating and net income surged, driven by Daily-Life Products and overseas recovery.3863
Q3 20266 Feb 2026 - Profit rebounded in H1 FY2026/3, but full-year outlook trimmed on weak export and Australia demand.3863
Q2 20266 Nov 2025 - Operating income soared and net loss narrowed, with major restructuring and bond issuance planned.3863
Q1 202519 Aug 2025 - Net sales and operating profit rose, but net income plunged 80% on impairment losses.3863
Q4 202519 Aug 2025 - Sales were stable but profits fell sharply; H2 recovery expected, led by overseas operations.3863
Q2 202519 Aug 2025 - Earnings rose on Daily-Life Products and Energy growth, but FX losses weighed on comprehensive income.3863
Q1 202619 Aug 2025